A carregar...
Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis
OBJECTIVE: To quantify comparative effectiveness of interleukin (IL)−12/23 antagonist (ustekinumab), IL-17A antagonists (secukinumab and ixekizumab), PDE4 inhibitor (apremilast) and tumour necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab)...
Na minha lista:
| Publicado no: | RMD Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8055145/ https://ncbi.nlm.nih.gov/pubmed/33863840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001399 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|